ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | -16.7% | 2,019 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $6,000 | -25.0% | 2,019 | 0.0% | 0.00% | -40.0% |
| Q4 2017 | $8,000 | -76.5% | 2,019 | -73.1% | 0.01% | -77.3% |
| Q3 2017 | $34,000 | +36.0% | 7,519 | 0.0% | 0.02% | +29.4% |
| Q2 2017 | $25,000 | -63.8% | 7,519 | 0.0% | 0.02% | -66.0% |
| Q1 2017 | $69,000 | +19.0% | 7,519 | 0.0% | 0.05% | -3.8% |
| Q4 2016 | $58,000 | -31.8% | 7,519 | 0.0% | 0.05% | -42.9% |
| Q3 2016 | $85,000 | -7.6% | 7,519 | 0.0% | 0.09% | -10.8% |
| Q2 2016 | $92,000 | +21.1% | 7,519 | 0.0% | 0.10% | +47.8% |
| Q1 2016 | $76,000 | -55.0% | 7,519 | 0.0% | 0.07% | -48.9% |
| Q4 2015 | $169,000 | +36.3% | 7,519 | 0.0% | 0.14% | -12.3% |
| Q3 2015 | $124,000 | -26.6% | 7,519 | 0.0% | 0.15% | -16.3% |
| Q2 2015 | $169,000 | -12.9% | 7,519 | 0.0% | 0.18% | -6.6% |
| Q1 2015 | $194,000 | +18.3% | 7,519 | 0.0% | 0.20% | +13.2% |
| Q4 2014 | $164,000 | – | 7,519 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |